# Pharmacokinetics of BIBB 515 BS and Effect of Food After Oral Administration in Healthy Subjects

> **NCT02266498** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BIBB 515 BS
- **OTHER:** Standard breakfast (40 g fat)

## Key facts

- **NCT ID:** NCT02266498
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06
- **Primary completion:** 1998-07
- **Final completion:** —
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02266498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02266498, "Pharmacokinetics of BIBB 515 BS and Effect of Food After Oral Administration in Healthy Subjects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02266498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*